Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Thomas D. Gazda, M.D. is a specialized clinical research site and psychiatric medical practice located in Scottsdale, Arizona. The organization focuses on conducting Phase II through Phase IV clinical trials for a wide range of central nervous system (CNS) and psychiatric indications, including schizophrenia, bipolar disorder, and major depression. Led by Dr. Thomas Gazda, a board-certified psychiatrist and experienced principal investigator, the site partners with global pharmaceutical companies and contract research organizations to evaluate new therapeutic interventions. The facility provides comprehensive trial management, from patient screening and recruitment to data collection and regulatory compliance. With a history of participating in hundreds of clinical studies, the practice is a recognized center for excellence in psychiatric research in the Southwest United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Thomas D. Gazda, M.D..